# US 2025/0143974 A1 · Adherence monitoring method and device

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0143974 A1
- Document ID: US20250143974A1
- Status: Published application
- Kind: A1
- Application number: 18/954,984
- Filed: 2024-11-21
- Published: 2025-05-08
- Earliest claimed: 2017-07-25
- Assignees: Adherium (Nz) Limited
- Applicants: Adherium (Nz) Limited
- Inventors: Hein BEYLEVELD; Michael James GORMACK; Tony Paul KIRKER; Benjamin Laurence WILSON
- Web page: https://patentgrep.com/patent/US20250143974A1

## CPC

- A61J 7/0418: {with electronic history memory}
- A61M 15/008: {Electronic counters}
- A61B 5/0022: {Monitoring a patient using a global network, e.g. telephone networks, internet}
- A61B 5/742: {using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339)}
- G16H 20/13: delivered from dispensers
- A61M 11/00: Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14})
- A61M 15/0025: {with caps}
- A61M 15/0035: {Piercing means}
- A61M 2205/0233: Conductive materials, e.g. antistatic coatings for spark prevention
- A61M 2205/18: with alarm
- A61M 2205/3317: Electromagnetic, inductive or dielectric measuring means
- A61M 2205/3327: Measuring
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/52: with memories providing a history of measured variating parameters of apparatus or patient
- A61M 2205/581: by audible feedback
- A61M 2205/583: by visual feedback
- A61M 2205/8281: spring operated
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

In one aspect the invention provides an adherence monitoring device for a medication delivery device, the monitoring device including at least one inductive coil sensor which includes at least one inductive controller, at least two inductive coils including a first inductive coil coupled to the housing and a second inductive coil coupled to the housing. The first inductive coil is configured to exhibit a response to an inductive change and provide a first change signal in response to an inductive change, and the second inductive coil is configured to exhibit a response to the inductive change and provide a second change signal in response to the inductive change. The monitoring device also includes a processor configured to receive sensor data from the inductive controller representative of the first and second change signals provided by the first inductive coil and second inductive coil and to compare at least one characteristic of the first change signal and the second change signal to detect the occurrence of a medication usage event or a false triggering event.

## Claims

### Claim 1

An adherence monitoring device for a medication delivery device, the adherence monitoring device comprising:
a housing with a hinged door;
at least one inductive coil sensor, within the housing, which includes at least one inductive controller, at least two inductive coils including a first inductive coil coupled to the housing and a second inductive coil coupled to the housing,
the first inductive coil configured to exhibit a response to an inductive change and provide a first change signal in response to an inductive change, and the second inductive coil configured to exhibit a response to the inductive change and provide a second change signal in response to the inductive change; and
a processor configured to receive sensor data from the inductive controller representative of the first and second change signals provided by the first inductive coil and second inductive coil and to compare at least one characteristic of the first change signal and the second change signal to detect the occurrence of a medication usage event or a false triggering event.

### Claim 2 (depends on 1)

The adherence monitoring device according to claim 1, wherein the first inductive coil and second inductive coil are positioned at different locations of the housing.
